Vascular diseases

Adamas Announces Settlement of Patent Litigation with Zydus

Retrieved on: 
Monday, February 1, 2021
Biotechnology, Health, Professional services, Pharmaceutical, Legal, Vascular diseases, Hypotension, Generic drug, Orthostatic hypotension, Health, GOCOVRI®, Adamas Pharmaceuticals, Inc.

We are focused on building on the momentum from our strong 2020 performance and delivering growth for GOCOVRI in 2021.

Key Points: 
  • We are focused on building on the momentum from our strong 2020 performance and delivering growth for GOCOVRI in 2021.
  • Upon entry of the joint stipulation and order, this settlement agreement will conclude all patent litigation brought to date by Adamas against generic pharmaceutical companies that filed an ANDA seeking approval to market generic versions of GOCOVRI prior to the expiration of the patents listed in the Orange Book.
  • The most commonly observed adverse reactions with GOCOVRI were hallucinations, dizziness, dry mouth, peripheral edema, constipation, falls and orthostatic hypotension.
  • At Adamas, our purpose is clear: deliver innovative medicines that make a clinically meaningful difference for patients, caregivers and society.

Outlook on the Vascular Patches Global Market to 2025 - Increasing Adoption of Biological Patches is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, January 29, 2021
Medical devices, Health, Medical specialties, Anatomy, Angiology, Gross pathology, Vascular surgery, Vascular diseases, IgG4-related disease, Aneurysm, Aortic aneurysm, Pseudoaneurysm, Aorta, Open aortic surgery

A small, localized saccular pseudoaneurysm of the aorta is often treated with quick patch repair rather than tube graft replacement.

Key Points: 
  • A small, localized saccular pseudoaneurysm of the aorta is often treated with quick patch repair rather than tube graft replacement.
  • This factor is also expected to increase the incidence of aortic aneurysm, which will increase the demand for vascular patches, helping in the market growth.
  • North America holds the largest share in the vascular patches market, with the United States being the largest contributor to its revenue.
  • Additionally, the increasing prevalence of vascular diseases is the major factor expected to drive the overall growth of the market, during the forecast period.

New York Tech Research Team Secures $1.8M NIH Grant to Investigate Vascular Decalcification as Heart Disease Treatment

Retrieved on: 
Wednesday, January 27, 2021
Circulatory system, Cardiovascular system, Medical specialties, Vascular diseases, Cardiovascular diseases, Atherosclerosis, Calcification, Cardiovascular disease, Artery, Heart, Monckeberg's arteriosclerosis

The $1.8 million grant, which includes a first-year award of $342,675, will support research toimprove the understanding of atherosclerosis (hardening of the arteries) and deliver a new treatment for heart disease.

Key Points: 
  • The $1.8 million grant, which includes a first-year award of $342,675, will support research toimprove the understanding of atherosclerosis (hardening of the arteries) and deliver a new treatment for heart disease.
  • NIH grant supports biomedical research that may lead to a new treatment for heart disease.
  • If it is a risk factor, treatments targeting calcification may prevent millions of future heart disease cases and fatalities.
  • The team will use mouse and computer models to investigate whethervascular calcification contributes to the development of atherosclerosis and, if so, whether a decalcification treatment can correct and prevent it.

Global Vascular Screening Devices Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 27, 2021
Medical devices, Health, Cardiovascular system, Circulatory system, Vascular diseases, Medical specialties, Aneurysm, Vascular disease, Cardiovascular disease, Coronary artery disease, Artery disease, Carotid artery stenosis, Vascular surgery

For several cardiovascular diseases, vascular screening tests become very important for further analysis and treatment.

Key Points: 
  • For several cardiovascular diseases, vascular screening tests become very important for further analysis and treatment.
  • Hence, early diagnosis and treatment are of utmost importance, which is expected to impact positively on the vascular screening test market.
  • North America expected to hold a major market share in the global vascular screening devices market, due to increased vascular diseases, such as coronary artery disease, renal artery diseases, and carotid artery aneurysm, among others.
  • Hence, the aforementioned factors are expected to boost up the demand for vascular screening devices in North America.

CES 2021 Mission for the human race, Pulxion's early detection technology is here to save lives

Retrieved on: 
Thursday, January 14, 2021
Angiology, Medical specialties, Cardiovascular system, Vascular diseases, Carotid artery stenosis, Neurosurgery, Vascular surgery, Stenosis, Common carotid artery, Stroke, Carotid ultrasonography, Carotid stenting

Pulxion's first product, PulStroke, is a novel fast-screening device for carotid artery stenosis, an early indicator of stroke.

Key Points: 
  • Pulxion's first product, PulStroke, is a novel fast-screening device for carotid artery stenosis, an early indicator of stroke.
  • Current clinical diagnosis procedures for early detection of carotid artery stenosis risk use Doppler ultrasound.
  • Therefore, patients without existing conditions are less willing to go through the assessment and thus lose the chance for early assessment and prevention.
  • These resources are accelerating the team's research and knowledge, and the company will be featured as a top-100 Taiwanese startup at CES 2021.

CES 2021 Mission for the Human Race, Pulxion’s Early Detection Technology Is Here to Save Lives.

Retrieved on: 
Thursday, January 14, 2021
Health, Technology, Hospitals, Other Health, Telecommunications, Mobile, Wireless, Software, Medical specialties, Angiology, Cardiovascular system, Vascular diseases, Carotid artery stenosis, Stroke, Neurosurgery, Vascular surgery, Stenosis, Common carotid artery, Carotid ultrasonography, Carotid stenting

Pulxions first product, PulStroke, is a novel fast-screening device for carotid artery stenosis, an early indicator of stroke.

Key Points: 
  • Pulxions first product, PulStroke, is a novel fast-screening device for carotid artery stenosis, an early indicator of stroke.
  • Current clinical diagnosis procedures for early detection of carotid artery stenosis risk use Doppler ultrasound.
  • Therefore, patients without existing conditions are less willing to go through the assessment and thus lose the chance for early assessment and prevention.
  • These resources are accelerating the teams research and knowledge, and the company will be featured as a top-100 Taiwanese startup at CES 2021.

Genuity Science Wins 2021 BIG Innovation Award for Novel Genome Sequencing Approach

Retrieved on: 
Tuesday, January 12, 2021
Angiology, Cardiovascular system, Circulatory system, Vascular diseases, IgG4-related disease, Vascular surgery, Genuity, Aortic aneurysm, Thoracic aortic aneurysm, Aneurysm, Analytics

BOSTON, Jan. 12, 2021 /PRNewswire/ -- Genuity Science , a genomics and data-sourcing, analytics and insights organization, today announced that it has been named a winner in the 2021 BIG Innovation Awards presented by the Business Intelligence Group.

Key Points: 
  • BOSTON, Jan. 12, 2021 /PRNewswire/ -- Genuity Science , a genomics and data-sourcing, analytics and insights organization, today announced that it has been named a winner in the 2021 BIG Innovation Awards presented by the Business Intelligence Group.
  • The BIG innovation Awards recognize those organizations and people who bring new ideas to life, and change the way we experience the world.
  • Genuity Science's AI technology sifted through a large amount of high-dimensional data without a starting hypothesis, allowing the teams to uncover novel causal connections at the single-cell level.
  • "We are honored to be recognized for our deep learning approach that helped, in part, discover the underlying cause of thoracic aortic aneurysms," said Tom Chittenden, PhD, DPhil, PStat, Chief Data Science Officer, Genuity Science.

Endospan Enrolls First Patient in the TRIOMPHE IDE Study

Retrieved on: 
Tuesday, January 12, 2021
Health, Medical devices, Surgery, Other Health, Clinical trials, Cardiology, Biotechnology, Medical specialties, Angiology, Cardiovascular system, Vascular diseases, Vascular surgery, Interventional radiology, Cardiac surgery, Aortic aneurysm, IgG4-related disease, Thoracic aortic aneurysm, Aneurysm, Stent

Endospan , a pioneer in off-the-shelf endovascular repair of aortic arch disease, announces the first implant of the NEXUS Aortic Arch Stent Graft System on a patient with a thoracic aortic aneurysm as part of the TRIOMPHE Study in Norfolk, Virginia, January 11, 2021.

Key Points: 
  • Endospan , a pioneer in off-the-shelf endovascular repair of aortic arch disease, announces the first implant of the NEXUS Aortic Arch Stent Graft System on a patient with a thoracic aortic aneurysm as part of the TRIOMPHE Study in Norfolk, Virginia, January 11, 2021.
  • The TRIOMPHE Study is a multi-arm, multi-center, non-randomized, prospective, clinical study to evaluate the safety and effectiveness of NEXUS in treating thoracic aortic lesions involving the aortic arch.
  • With the first patient enrolled in the TRIOMPHE IDE study, Endospan marks the next crucial milestone towards US approval for the NEXUS Aortic Arch Repair Stent Graft System, said Kevin Mayberry, CEO.
  • The NEXUS is specifically engineered for total endovascular arch repair to address the specific challenges of the aortic arch anatomy.

Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval

Retrieved on: 
Tuesday, January 12, 2021
Medical specialties, Vascular diseases, Gross pathology, Branches of biology, Neurosurgery, Clinical medicine, Aneurysm, Bifurcation, Cerebrovascular diseases, Flow diverter, Interventional radiology

The WEB System is a unique, single-device treatment solution for wide neck bifurcation aneurysms in a new category of devices called intrasaccular flow disruptors.

Key Points: 
  • The WEB System is a unique, single-device treatment solution for wide neck bifurcation aneurysms in a new category of devices called intrasaccular flow disruptors.
  • When placed inside the aneurysm sac, the WEB device's proprietary microbraid technology bridges the aneurysm neck, disrupting blood flow, and creates a scaffold for long-lasting treatment.
  • "The excellent clinical results we can achieve with intrasaccular flow disruption technology has changed the way we approach the treatment of wide neck bifurcation aneurysms, and the WEB 17 System expands upon that.
  • When placed inside the aneurysm sac, the WEB device's proprietary microbraid technology bridges the aneurysm neck, disrupting blood flow, and creates a scaffold for long-lasting treatment.

United States $4.6 Billion Peripheral Vascular Devices and Accessories Market to 2027

Retrieved on: 
Monday, January 11, 2021
Vascular diseases, Interventional radiology, Chronic venous insufficiency, Stent, Insufficiency

The U.S. peripheral vascular devices and accessories market size is expected to reach USD 4.6 billion by 2027, expanding at a CAGR of 4.5%

Key Points: 
  • The U.S. peripheral vascular devices and accessories market size is expected to reach USD 4.6 billion by 2027, expanding at a CAGR of 4.5%
    Growing prevalence of venous diseases or Chronic Venous Insufficiency (CVI) is one of the key factors driving the growth of the market.
  • In addition, the peripheral stent market is majorly driven by a growing patient pool requiring the immediate stent placement, technological innovations in peripheral vascular interventions, and growing number of government initiatives.
  • Peripheral Devices & Accessories Market Variables, Trends, & Scope
    3.6 Number of Peripheral Vascular Procedures Performed, 2016 - 2027
    3.7 Average Cost of Peripheral Vascular Procedures, 2016 - 2027
    3.8 Average Selling Price (ASP) Analysis, By Product Type, 2016 - 2027
    Chapter 4 U.S.
  • Peripheral Devices & Accessories Market: Competitive Analysis
    4.1 Recent Developments & Impact Analysis, by Key Market Participants
    4.2 Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
    4.3 Key Company Market Share Analysis, 2019